BMT, Malignant Hematology, or Cellular Therapy - Faculty Physician - University of Minnesota
University of Minnesota
Hematology, Oncology, and Transplantation
Minneapolis, MN, USA
Faculty, Patient Care, Research, Academic/Administrative, Allied Health, Training/Fellowship, Other
June 23, 2021
Medical School, Hospital/Clinical Facility, Non-Profit Research Institute, Other
November 17, 2021-March 10, 2022
University of Minnesota Physicians, the Division of Hematology, Oncology & Transplantation, the Masonic Cancer Center, and The University of Minnesota are seeking applicants for an Assistant Professor or Associate Professor clinically trained in Malignant Hematology, BMT, or Cellular Therapy.
About the Position: The primary clinical practice will include inpatient and ambulatory care at the University of Minnesota. Responsibilities will include clinical care, research, teaching residents and fellows.
Appointment on clinical scholar track in an academic setting to provide care to patients with hematologic malignancies where you will have access to the latest and most advanced treatment options, clinical trials, and scientific advances. Join a division where you’ll be supported by nationally and internationally recognized leaders including over 35 faculty physicians; with 15 dedicated to BMT and Malignant Hematology. Protected academic time to pursue and develop academic interests. Opportunity to develop and contribute to research, educational, and clinical initiatives related to your area of interest and expertise.
About the Division: The Division of Hematology, Oncology, and Transplantation is comprised of leading experts in the treatment of hematologic malignancies and immune deficiencies, dedicated to seeking new approaches to achieve more effective therapies while reducing or minimizing the effects of treatment, both in the laboratory and in our state of the art facilities. The Masonic Cancer Clinic is a hematologic malignancy clinic, serving the Twin Cities area, with outreach throughout the state of Minnesota. The Masonic Cancer Center is one of the nation’s top cancer research centers and is designated by the National Cancer Institute as an ‘Outstanding’ Comprehensive Cancer Center.
Currently, more than 225 clinical trials are open to treat over 100 different types of cancer. The BMT & Cellular Therapy Program has been at the forefront of advances since performing the world’s first successful BMT in 1968. Since then, our teams have performed more than 8,000 Bone Marrow Transplants. The Malignant Hematology Program works closely with the BMT & Cellular Therapy Program and has expertise in the design and development of new cellular and immunotherapies, including phase I/II trials of CAR T-cell therapies and natural killer cellular therapies for the treatment of lymphoma, myeloma, acute leukemia’s, and other hematologic malignancies. We are committed to diversity in all areas, including scholarship, instruction, and engagement at all levels.
Our faculty-led multidisciplinary teams in the inpatient settings care for patients with a wide variety of hematologic malignancies and have access to cutting-edge therapies and innovative clinical trials. We have pioneered novel approaches particularly in the field of cellular therapy, NK cells immunobiology, umbilical cord blood transplantation, and novel leukemia and lymphoma therapies. This group is particularly strong in bone marrow transplantation and cellular therapies and works across disciplines to integrate University centers and programs to rapidly advance translational and clinical research in hematologic malignancies.
How to Apply
To view our live job postings visit:
For more information or questions contact: Samantha Wormley at firstname.lastname@example.org
720 Washington Ave SE
Minneapolis, MN 55414 USA
back to top